Joseph S. Durgin

Rapid manufacturing of non-activated potent CAR T cells

Saba Ghassemi, Joseph S. Durgin, Selene Nuñez-Cruz et al. · Nature Biomedical Engineering · 2022 · 280 citations · Full text

Life Sciences, Biotechnology, Immunology +14

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma

Joseph S. Durgin, Fraser Henderson, MacLean P. Nasrallah et al. · Frontiers in Oncology · 2021 · 74 citations · Full text

Medicine, Immunology, Oncology +17

Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach

Robert Kueffner, Neta Zach, Maya Bronfeld et al. · Scientific Reports · 2019 · 56 citations · Full text

Computing, Data Science, Neurology +17

Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase

Joseph S. Durgin, Radhika Thokala, Lexus R. Johnson et al. · Molecular Therapy · 2021 · 32 citations · Full text

Life Sciences, Immunology, Oncology +12

Comparing the quality of ChatGPT- and physician-generated responses to patients’ dermatology questions in the electronic medical record

Kelly A. Reynolds, Daniel A. Nadelman, Joseph S. Durgin et al. · Clinical and Experimental Dermatology · 2024 · 27 citations

Computing, Computer Science, Dermatology +15